3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Carcinoma, Non-Small-Cell Lung
5
Stomach Neoplasms
3
Pancreatic Neoplasms
3
Carcinoma, Renal Cell
3
Triple Negative Breast Neoplasms
2
Lung Neoplasms
2
Kidney Neoplasms
2
Adenocarcinoma Of Esophagus
2
Uterine Cervical Neoplasms
1
Urothelial Bladder Carcinoma
1
Urinary Bladder Neoplasms
1
Squamous Cell Carcinoma of Head and Neck
1
Solid Tumors
1
Recurrence
1
Ovarian Neoplasms
1
Metastatic Urothelial Cancer
1
Melanoma
1
Lung Diseases
1
Glioblastoma
1
Esophageal Neoplasms
1
Erythrocytosis, Familial, 4
1
Cholangiocarcinoma
1
Advanced Solid Tumors
1
Advanced Non-Small Cell Lung Cancer
1
Interventions
Cisplatin
22
Magnetic Resonance Spectroscopy
15
Specimen Handling
13
Platinum
12
Radiotherapy, Intensity-Modulated
11
1,2-diaminocyclohexaneplatinum II citrate
11
Radiotherapy
10
Radiation
10
Carboplatin
9
Biopsy
5
pembrolizumab
4
Taxes
4
Surveys and Questionnaires
4
Paclitaxel
4
Nivolumab
4
Docetaxel
4
Chemoradiotherapy
4
Cetuximab
4
Fluorodeoxyglucose F18
3
(225)Ac-DOTA-c(RGDyK)
3
durvalumab
2
X-Rays
2
Standard of Care
2
Radiotherapy, Image-Guided
2
Observation
2
Interviews as Topic
2
Immunoglobulin G
2
Fluorouracil
2
Disulfides
2
toripalimab
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Oropharyngeal Neoplasms
×
zimberelimab
×
90 days
×
Clear all
No trials found.